540359 Stock Overview
Parmax Pharma Limited operates in the pharmaceutical business in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Parmax Pharma Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹29.99 |
| 52 Week High | ₹36.58 |
| 52 Week Low | ₹24.18 |
| Beta | 0 |
| 1 Month Change | 2.01% |
| 3 Month Change | -8.40% |
| 1 Year Change | -9.80% |
| 3 Year Change | -32.00% |
| 5 Year Change | 73.35% |
| Change since IPO | 139.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540359 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.9% | -3.0% | -1.7% |
| 1Y | -9.8% | 56.8% | 45.0% |
Return vs Industry: 540359 underperformed the Indian Pharmaceuticals industry which returned 56.8% over the past year.
Return vs Market: 540359 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 540359 volatility | |
|---|---|
| 540359 Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 540359 has not had significant price volatility in the past 3 months.
Volatility Over Time: 540359's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Umang Gosalia | www.parmaxpharma.com |
Parmax Pharma Limited operates in the pharmaceutical business in India. It manufactures and sells bulk drugs, drug intermediates, and specialty chemicals. The company was incorporated in 1994 and is based in Rajkot, India.
Parmax Pharma Limited Fundamentals Summary
| 540359 fundamental statistics | |
|---|---|
| Market cap | ₹112.20m |
| Earnings (TTM) | ₹0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 540359 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540359 income statement (TTM) | |
|---|---|
| Revenue | ₹0 |
| Cost of Revenue | ₹0 |
| Gross Profit | ₹0 |
| Other Expenses | ₹0 |
| Earnings | ₹0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 540359 perform over the long term?
See historical performance and comparison